This cohort study investigates whether the potential association of modifiable risk factors with prostate cancer varies across genetic risk profiles and age.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Prostate-Specific Membrane Antigen Imaging and Initial Treatment for Prostate Cancer | 0 | 10.24 | 01-07-2026 |
| 2 | Treatment Delays in Early Age–Onset Colorectal Cancer | 0 | 8.3 | 01-07-2026 |
| 3 | Tumor-Infiltrating Clonal Hematopoiesis and Pan-Cancer Prognosis in Patients With Solid Tumors | 0 | 11.9 | 01-07-2026 |
| 4 | Actionable Signals in Pancreatic Cancer Risk Scores | 0 | 7.13 | 01-10-2026 |
| 5 | Rates of Systemic Treatment for Metastatic Non–Small Cell Lung Cancer Among Older Adults | 0 | 5.92 | 01-07-2026 |
| 6 | Actionable Signals in Pancreatic Cancer Risk Scores—Reply | 0 | 9.8 | 01-10-2026 |
| 7 | Long-Term Adverse Effects and Complications After Prostate Cancer Treatment | 0 | 9.73 | 01-12-2024 |
| 8 | Familial Melanoma Genes and Cancer Risk Among Genomically Ascertained Individuals | 0 | 6.31 | 01-07-2026 |
| 9 | Breast and Ovarian Cancer Among Individuals Undergoing BRCA1 and BRCA2 Testing | 0 | 11.9 | 30-07-2026 |
| 10 | Prostate Cancer Mortality After Relabeling Low-Grade Prostate Cancer as Precancerous | 0 | 9.66 | 01-07-2026 |